Mo. Federal Judge Refuses to Transfer, Consolidate Case Targeting Gilead’s HIV Drugs



DOCUMENTS
  • Order


ST. LOUIS — A Missouri federal judge has refused to transfer a putative class action targeting Gilead Sciences Inc.’s HIV drugs to consolidate it with 48 other cases pending against the company in California federal court, ruling it would prejudice the plaintiffs.

In a Jan. 26 order, Judge Matthew T. Schlep of the U.S. District Court for the Eastern District of Missouri noted the California litigation is at an advanced stage in the proceedings and involves personal injury claims, whereas the claims in the instant action are for unfair or deceptive practices and unjust enrichment.

Gilead simultaneously developed tenofovir disoproxil …

FIRM NAMES
  • Brenes Law Group
  • Calabro Law Office
  • Hepler Broom
  • Sidley Austin LLP





UPCOMING CONFERENCES




HarrisMartin's Camp Lejeune Water Contamination Litigation Conference

July 29, 2022 - St. Louis, MO
Four Seasons Hotel, St. Louis

MORE DETAILS



HarrisMartin's Midwest Asbestos Litigation Conference

September 23, 2022 - St. Louis, MO
Four Seasons Hotel, St. Louis

MORE DETAILS